510(k) Report

510(k) · Cleared

Cleared

XW-100 Automated Hematology Analyzer for CLIA Waived Use

K172604510(k) Dual TrackCleared Nov 6, 201768-day reviewClass II21 CFR 864.5220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sysmex America, Inc. · GKZ Counter, Differential Cell

Cleared on Nov 6, 2017 as substantially equivalent to K143577 (Sysmex America, Inc., 2015) after a 68-day review. Its family tree reaches back 2 generations to 1985. 1 later device descends from it.

Decided
Nov 6, 2017
Review
68 days
Class
Class II
Product code
GKZ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K852992 (1985). 1 later device descends from it, 1 citing it directly.

  1. Root · 2 generations backK852992 Para Check (Aka Eight Check-C)Streck Laboratories, Inc. · 1985
  2. 1 generation backK143577 XW-100 Automated Hematology Analyzer, XW QC CHECKSysmex America, Inc. · 2015
  3. This deviceK172604 XW-100 Automated Hematology Analyzer for CLIA Waived UseSysmex America, Inc. · 2017
  4. Descendant · cites it directly · 0 of its ownK210346 Sysmex XW-100 Automated Hematology AnalyzerSysmex America, Inc. · 2022

Most influential descendants

Showing 1 of 1 · See all
  • K210346Sysmex XW-100 Automated Hematology AnalyzerSysmex America, Inc. · 2022 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K852992Para Check (Aka Eight Check-C)Streck Laboratories, Inc.1985—
−1K143577XW-100 Automated Hematology Analyzer, XW QC CHECKSysmex America, Inc.2015—
0 (this device)K172604XW-100 Automated Hematology Analyzer for CLIA Waived UseSysmex America, Inc.2017—
+1K210346Sysmex XW-100 Automated Hematology AnalyzerSysmex America, Inc.2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
FIG. 1 — Lineage of K172604, 1985–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GKZ device

  1. #1 K250943 Sysmex XR-Series (XR-10) Automated Hematology…score 13.2 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K143577XW-100 Automated Hematology Analyzer, XW QC CHECK
Summary page 5
…Sysmex XW-100 Automated Hematology Analyzer for Point of Care Use. 6. Clinical performance data Please reference k143577 for clinical performance data and CW170004 for clinical field data and flex studies. 7. Conclu…
Sysmex America, Inc.2015—
†K943268SCS-1000 (Sysmex Calibrator System)Streck Laboratories, Inc.1994—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K210346Sysmex XW-100 Automated Hematology AnalyzerSysmex America, Inc.20220

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 32 years and passes through 2 companies; a new generation was cleared every 30.0 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K210346 (Sysmex America, Inc., 2022) has gone furthest, with 0 descendants of its own.

How does its category compare?

All GKZ devices

GKZ Counter, Differential Cell: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · GKZ

4in 2025

2007: 62008: 62009: 62010: 42011: 32012: 32013: 12014: 32015: 32016: 32017: 42018: 32019: 52020: 12022: 32023: 42024: 32025: 42026 (partial year): 4
2007high 6 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GKZ

108in 2025

2007: 117 days median2008: 99 days median2009: 147 days median2010: 290 days median2011: 315 days median2012: 408 days median2014: 165 days median2015: 273 days median2016: 198 days median2017: 280 days median2018: 270 days median2019: 210 days median2022: 638 days median2023: 329 days median2024: 157 days median2025: 108 days median2026 (partial year): 254 days median
2007high 638 (2022) · low 99 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GKZ

1in 2025

2007: 372008: 52009: 132010: 272011: 282012: 72013: 62015: 32016: 32017: 32018: 2, 2 Class I2019: 22020: 12022: 42023: 12025: 1
2007high 37 (2007) · low 0 (2014)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · GKZ

77in 2025

2007: 2682008: 9252009: 5592010: 8962011: 2,9052012: 2,9592013: 3,0702014: 3,1122015: 1,9722016: 3,3382017: 2292018: 4972019: 9082020: 3422021: 3912022: 1982023: 1552024: 1152025: 77
2007high 3,338 (2016) · low 77 (2025)2025

MAUDE reports naming product code GKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611737268
20086995925
2009614713559
2010429027896
20113315282,905
2012340872,959
20131—63,070
2014316503,112
2015327331,972
2016319833,338
201742803229
201832702 (2)497
201952102908
20201—1342
20210—0391
202236384198
202343291155
202431570115
20254108177
202642540—

What is it indicated for?

The XW-100 Automated Hematology Analyzer (XW-100) is a quantitative automated hematology analyzer intended for in vitro diagnostic use to classify and enumerate the following parameters for venous whole blood anticoagulated with K2/K3 EDTA: WBC, RBC, HGB, HCT, MCV, PLT, LYM%, Other WBC%, NEUT%, LYM#, Other WBC#, and NEUT#. It is not for use in diagnosing or monitoring patients with primary or secondary chronic hematologic diseases/disorders, oncology patients, critically ill patients, or children under the age of 2.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K172604: XW-100 Automated Hematology Analyzer for CLIA Waived Use.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K172604

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026